PharmaTECH Kazakhstan 2026

PharmaTECH Kazakhstan 2026: Shaping the New Era of Pharmaceutical Industry

In May 2026, Almaty will once again become the focal point for industry leaders. Iteca, the leading exhibition company in Kazakhstan, with the official support of the Ministry of Healthcare of the Republic of Kazakhstan, SK-Pharmacy, and key industry associations, presents the 3rd Kazakhstan International Exhibition for Equipment, Raw Materials and Technologies for Pharmaceutical Industry - PharmaTECH Kazakhstan.

Why 2026 is a Turning Point for the Market?

The pharmaceutical sector in Kazakhstan has transitioned from a stage of "active growth" to "profound structural transformation." Today’s agenda is driven by fundamental economic and regulatory shifts:

  • New Tax Reality: The introduction of a 5% VAT on pharmaceuticals and medical devices as of January 1, 2026, requires companies to fully optimize their production and logistics costs.
  • Price Deregulation: The transition to market-based pricing for a significant portion of drugs creates new opportunities for business profitability while demanding innovative technologies to remain competitive.
  • Localization: Following the milestone of 50% domestic production share, the focus has shifted towards high-tech R&D centers and the production of original drugs in partnership with global giants like Pfizer, Roche, and AstraZeneca.

Facts & Figures

Kazakhstan reinforces its status as the key pharmaceutical hub of Central Asia:

  • Domestic production in 2025 showed steady growth, exceeding 150 billion KZT.
  • Over 190 manufacturing sites are actively operating and upgrading across the country.
  • The implementation of 100% mandatory labeling and traceability systems by 2026 has brought total transparency, paving the way for AI and Big Data solutions.

PharmaTECH Kazakhstan 2026: More Than Just an Exhibition

It is a strategic platform for solving core business challenges:

  • Technological Upgrade: Direct access to equipment suppliers for GMP and GDP-compliant facilities.
  • Supply Chain Security: Sourcing alternative APIs and ingredients amidst changing global logistics.
  • Regulatory Dialogue: Direct communication with government officials and experts regarding taxation, registration, and off-take contracts.

Exhibition sections cover the full cycle: from cleanroom engineering and lab analysis to packaging, labeling, and cold chain logistics.

Join the industry leaders! Future of Kazakhstan’s pharma is built here.